Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab

BACKGROUND: Currently, there are no known effective treatments for recurrent glioblastoma once patients have progressed on a bevacizumab-containing regimen. We examined the efficacy of adding nitrosoureas to bevacizumab in patients who progressed while on an initial bevacizumab-containing regimen. M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rahman, Rifaquat, Hempfling, Kelly, Norden, Andrew D., Reardon, David A., Nayak, Lakshmi, Rinne, Mikael L., Beroukhim, Rameen, Doherty, Lisa, Ruland, Sandra, Rai, Arun, Rifenburg, Jennifer, LaFrankie, Debra, Alexander, Brian M., Huang, Raymond Y., Wen, Patrick Y., Lee, Eudocia Q.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201074/
https://ncbi.nlm.nih.gov/pubmed/24958095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou118
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars